Selecting suitable materials to avoid radioiodine contamination Uranium in glass

doi:10.1088/0952-4746/30/4/l01

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2012

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 13 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The use of nasogastric or percutaneous endoscopic gastrostomy tubes present potential hazards due to RAI adherence to plastic [36,37]. To avoid this, endoscopic administration of capsules has been successfully utilised [38], although this is unlikely to be routinely available.…”

Section: Discussionmentioning

confidence: 99%

Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK

Wadsley¹,

Armstrong²,

Bassett-Smith³

et al. 2023

Clinical Oncology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK

Wadsley¹,

Armstrong²,

Bassett-Smith³

et al. 2023

Clinical Oncology

View full text Add to dashboard Cite

Radioiodine retention on percutaneous endoscopic gastrostomy tubes

Scuffham¹,

Wood²,

Clauss³

et al. 2012

BJR

View full text Add to dashboard Cite

An 80-year-old male with recurrent thyroid cancer and a percutaneous endoscopic gastrostomy (PEG) tube in situ was referred for radioiodine therapy and was administered 5510 MBq I-131 sodium iodide intravenously. Sequential whole-body images taken over the subsequent 7 days for dosimetric evaluation revealed an area of persistent high uptake in the abdomen. Delayed imaging with single photon emission CT/CT at 15 days post administration revealed this uptake to be at the junction of the PEG tube with the anatomically normal stomach wall. We hypothesise that the PEG tube became contaminated by radioiodine secreted in the gastric mucosa during therapy and this radioactivity subsequently decayed with an increased effective half-life relative to the stomach, leading to the apparent hot spot.

show abstract

Selecting suitable materials to avoid radioiodine contamination Uranium in glass

Abstract: The full text of the Letters in this issue is given in the PDF file.

Cited by 2 publications

References 13 publications

Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK

Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK

Radioiodine retention on percutaneous endoscopic gastrostomy tubes

Contact Info

Product

Resources

About